Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about EXEL

Recent news which mentions EXEL

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Buying These 3 Stocks Could Be the Smartest Investing Move You Ever Make
Tickers BMY ETSY EXEL IPSEY
Tags BMY IPSEY Market News
From Motley Fool
Exelixis (EXEL) Q1 2022 Earnings Call Transcript
Tickers EXEL
Tags Market News EXEL Recent Press Releases
From Motley Fool
Exelixis: Q1 Earnings Insights
Tickers EXEL
Tags EXEL Benzinga BZI/Recaps
From Benzinga
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
Tickers AGEN ARWR ATNX AVGR
Tags AVGR EVAX BHVN
From Benzinga
3 Growth Stocks to Buy With $1,000 Right Now
Tickers BMY CURLF EXEL PINS
Tags Recent Press Releases PINS EXEL
From Motley Fool
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
Tickers ACAD AQST BIIB BLTE
Tags OCUL BPMC Penny Stocks
From Benzinga
Ipsen - Exelixis' Cabometyx Scores European Approval As Second-Line Treatment For Thyroid Cancer
Tickers EXEL IPSEF IPSEY
Tags EXEL General Biotech
From Benzinga
7 Top-Rated Biotech Stocks to Buy for Q2
Tickers BCRX BNTX EXEL ITOS
Tags PFE MRUS MRNA
From InvestorPlace
Nasdaq Bear Market: 3 of the Safest Stocks to Buy on the Dip
Tickers AVGO BRK-A BRK-B EXEL
Tags Market News BRK/A AVGO
From Motley Fool
3 No-Brainer Stocks to Buy With $1,000 During the Market Sell-Off
Tickers AVGO EXEL FB
Tags FB Market News AVGO
From Motley Fool
2 Stocks Defying the Market Sell-Off Right Now
Tickers BMY EXEL
Tags Recent Press Releases EXEL Market News
From Motley Fool
EMA's Scientific Committee Backs Expanded Use Of Exelixis, Ipsen's Cabometyx In Thyroid Cancer
Tickers EXEL IPSEF IPSEY
Tags News IPSEF European Medicines Agency
From Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
Tickers ALT ANAB ANIP ATHX
Tags IMRA GMDA ATHX
From Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
Tickers BAYRY BAYZF EXEL IPSEY
Tags BAYZF Hepatocellular Carcinoma Biotech
From Benzinga
3 Stocks That Can Turn $10,000 Into $50,000 by 2025
Tickers EXEL FIGS NVAX
Tags NVAX Market News Recent Press Releases
From Motley Fool
2 Biotech Stocks That Could Make You Richer
Tickers BMY EXEL ICPT RHHBY
Tags ICPT EXEL Recent Press Releases
From Motley Fool
3 Surefire Stocks to Buy Hand Over Fist During the Stock Market Sell-Off
Tickers EXEL GM MA
Tags EXEL Recent Press Releases GM
From Motley Fool
Exelixis (EXEL) Q4 2021 Earnings Call Transcript
Tickers EXEL
Tags Market News EXEL Recent Press Releases
From Motley Fool
Exelixis: Q4 Earnings Insights
Tickers EXEL
Tags EXEL Earnings Market News
From Benzinga
Earnings Scheduled For February 17, 2022
Tickers AAWW AEE AEL AL
Tags OEC DRH GDEN
From Benzinga
Earnings Preview For Exelixis
Tickers EXEL
Tags EXEL Benzinga BZI/EP
From Benzinga
Bristol Myers, Exelixis Tout Additional Opdivo/Cabometyx Combo Data From Kidney Cancer Trial
Tickers BMY EXEL
Tags Market News BMY renal cell carcinoma
From Benzinga
2 Biotech Stocks That Could Make You Richer
Tickers BLUE EXEL TSVT
Tags Market News BLUE EXEL
From Motley Fool
5 Value Stocks That Can Make You Richer in 2022
Tickers AGNC EXEL FB GM
Tags Recent Press Releases T EXEL
From Motley Fool
3 Biotech Stocks Wall Street Thinks Could Soar 50% or More in 2022
Tickers ARKG BMY CRSP EXEL
Tags Recent Press Releases EXEL CRSP
From Motley Fool
A Peek Into The Markets: US Stock Futures Edge Higher; Crude Oil Up 0.5%
Tickers ACN AZZ CMC EXEL
Tags News CMC Market News
From Benzinga
7 of the Best Cheap Stocks Under $20 for 2022 to Buy Now
Tickers AAL EXEL MOMO ORAN
Tags Stocks to Buy VTRS VOD
From InvestorPlace
The Daily Biotech Pulse: Novartis Snags Twin FDA Nods, Novavax Positive Vaccine News Continues, Arcutis Psoriasis Application Accepted For Review
Tickers ADAG ALNY ARQT EXEL
Tags GILD Penny Stocks ADAG
From Benzinga
2 Growth Stocks Analysts Think Can Double Within 2 Years
Tickers EXEL FUBO
Tags Recent Press Releases EXEL Market News
From Motley Fool
Got $1,000? These 3 Stocks Could Be Bargain Buys for 2022 and Beyond
Tickers EXEL SGEN VRTX
Tags SGEN EXEL Recent Press Releases
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.